Jay S. Pepose, M.D., Ph. D, Mujtaba Qazi, MD, and Jonathan Crews, DO with Midwest Vision Research Foundation at Pepose Vision Institute in St. Louis, Mo., are participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.
“Over the course of my career, I have made it my mission to deliver the best outcomes possible for my cataract patients,” Dr. Pepose said. “That it is why it is so exciting for me and the entire Pepose Vision team to be part of the AcuFocus IC-8 lens clinical study. During the study, we will be exploring whether small aperture technology can be used with a traditional IOL to extend a cataract patient’s range of vision from near to far.”
By the age of 65, an estimated 90% of people worldwide experience changes to the natural crystalline lens of the eye. The lens gradually becomes cloudy as a cataract develops leading to blurry vision and eventually vision loss. The only solution to a cataract is the surgical removal of the natural lens and its replacement with an artificial lens called an IOL. More than 25 million cataract procedures are performed worldwide each year. The majority of patients with cataracts are treated with astandardmonofocal (single-focus) lens,which allows the patient to have excellent far vision; however, patients remain dependent on glasses for near and intermediate vision.
Dr. Pepose, Dr. Qazi, and Dr. Crews will be three of a select group of clinical investigators across the United States for the IC-8 lens study. The IC-8 lens is a clear monofocal lens with a mini-ring placed in the center. The mini-ring has an opening, or pinhole, designed to increase the range of vision by extending the focus of light rays that enter the eye. The clinical study will determine if the IC-8 lens in one eye, when paired with a standard monofocal lens in the other eye, will provide near and intermediate vision in addition to far vision for cataract patients.
The Midwest Vision Research Foundation at Pepose Vision Institute is now enrolling patients that meet the study eligibility criteria. Patients who comply with study commitments will be compensated. Some basic qualifications include the following:
- At least 22 years of age.
- Have cataracts in both eyes.
- Are available, willing and able to participate in examinations and all follow-up study visits and appointments.
If you are interested in becoming a volunteer participant in the IC-8 lens clinical study, please contact Lee Collier at the Midwest Vision Research Foundation at Pepose Vision Institute at (636) 534-5126 or at lcollier@MidwestVRF.org.
ABOUT US
Pepose Vision Institute is St. Louis’ premier multi-specialty vision care practice providing advanced treatments including glaucoma, LASIK, custom cataract surgery, retina services/macular degeneration, dry eyes and allergies, preventive eye care and more.
Pepose Vision Institute
1815 Clarkson Rd. Chesterfield, Missouri 63017
13134 Tesson Ferry Road St. Louis, MO 63128
636-728-0111 Toll free: 877.862.2020 www.peposevision.com
ABOUT ACUFOCUS & THE IC-8 IOL
AcuFocus, Inc., is a privately held ophthalmic medical device company that develops and markets breakthrough technologies for the improvement of vision. The IC-8 lens received its CE mark in 2014 and is available in select markets across Europe and Asia. Founded in 2001, AcuFocus is based in Irvine, Calif. For additional information about the IC-8 intraocular lens, visit www.ic8lensclinicalstudy.com or https://www.facebook.com/ic8lensclinicalstudy.
Caution: Investigational Device. Limited by Federal (or United States) law to investigational use.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190124005271/en/
Source: Pepose Vision Institute
View this news release online at:
http://www.businesswire.com/news/home/20190124005271/en
